Medline Inc. Class A Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Medline Inc. Class A Common Stock trades at $35.67 (market cap $31.36B), while Revolution Medicines Inc. Common Stock trades at $186.54 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is the larger of the two by market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| MDLN | RVMD | |
|---|---|---|
Market Cap | $31.36B | $40.32B |
Volume | 10,191,251 | 4,855,734 |
Sector | Health | Health |
52-Week High | $49.99 | $221.15 |
52-Week Low | $31.64 | $47.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $41.32B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →